AEON Biopharma, Inc. (AEON) financial statements and ratios from SEC XBRL: revenue $3.71M (TTM), net margin 172.0%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.71M |
| Net Margin | 172.0% |
| FCF Yield | -91.5% |
| Sector P/E (Healthcare) | 21.7 |
AEON overview · AEON earnings · AEON KPIs · AEON investor relations · AEON ownership · AEON peers · AEON filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.